Over-the-Counter Product Role in the Daily Management of Atopic Dermatitis: Achieving Success With Advanced Technology

July 2013 | Volume 12 | Issue 7 | Supplement | s84 | Copyright © 2013

Leon H. Kircik MD

Abstract

No abstract available

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close
table 1

As understanding of the structure and function of the epidermal barrier has improved over the past several years, treatment strategies for various dermatologic conditions have changed to incorporate barrier support and repair. Barrier support is now commonly used for atopic dermatitis,1,2 as well as for other inflammatory diseases of the skin such as psoriasis, acne, and rosacea. The market for epidermal barrier repair formulations is large, and it includes both prescription and over-the-counter (OTC) options. The cost of these formulations varies widely and, because of their approval status as a medical device rather than a drug, some third-party payers unfortunately may not cover prescription barrier therapies, thus limiting their use.

Cetaphil® Restoraderm® Moisturizer (Galderma Laboratories, L.P.; Fort Worth, TX) and its associated Body Wash from Galderma are a welcome OTC option for atopic dermatitis patients. Restoraderm Body Wash and Moisturizer are specifically created to address the needs of atopic dermatitis patients, both adult and pediatric. Of note, the Restoraderm product line is formulated with advanced ceramide technology and filaggrin breakdown products to support the natural components of the epidermal barrier.

Cetaphil Restoraderm products are widely available and competitively priced, making them accessible to a large majority of the patient population.

The emerging and available data on epidermal barrier function and its repair confirm that barrier support is a crucial element in treating patients with atopic dermatitis and several other common dermatoses. As discussed in the pages ahead, the Restoraderm Body Wash and Moisturizer product line has extensive clinical data to support its positive effect on the epidermal barrier system in atopic patients.

Leon H. Kircik MD

Mount Sinai Medical Center, New York, NY
Indiana University School of Medicine, Indianapolis, IN
Physicians Skin Care, PLLC, Louisville, KY

Disclosures

Dr. Kircik has received compensation from the Journal of Drugs in Dermatology for his editorial support.

References

  1. Wollenberg A, Schnopp C. Evolution of conventional therapy in atopic dermatitis. Immunol Allergy Clin North Am. 2010;30(3):351-368.
  2. Elias PM, Wakefield JS. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol. 2011;41(3):282-295.

↑ back to top


  • 1

Related Articles